News
Read the latest news from Health. Watch out for current health warnings. And find out how you can have your say on issues that affect you.
Ministers' media
Stay up to date with ministerial media releases, transcripts and speeches on our ministers’ website.
Keep up-to-date with health warnings. Get involved in current consultations.
![Flu (influenza) vaccines]()
Meningococcal B vaccine and clinical advice for immunisation providers regarding the use of Bexsero® (4CMenB). From 5 March 2014, the recombinant multicomponent meningococcal B vaccine Bexsero® (4CMenB) became available through purchase on the private market.
![Image of a mother holding her young child]()
Advice for vaccination providers about maternal vaccination through the National Immunisation Program from 1 July 2018.
![Protect yourself and your baby - vaccines against whooping cough and influenza are free in pregnancy.]()
Vaccination is the best way for pregnant women to protect themselves and their babies from whooping cough and influenza.
![Three young kids image - public consutation re meningococcal and haemophilus tupe B vax recommendations]()
The Australian Technical Advisory Group on Immunisation is consulting with stakeholders on proposed changes to meningococcal and Haemophilus influenzae type B vaccination recommendations for inclusion in the Australian Immunisation Handbook.
![Older Australian consulting with their doctor]()
Advice on the presence of natural rubber latex in the sheath covering the needle of the Fluad trivalent influenza vaccine. Anyone who has a severe allergy to latex should not receive Fluad.
![The-Zostavax-vaccine-GP-appointment-image]()
The Zostavax® vaccine is now available nationally for immunisation providers for people aged 70 to 79 years under the National Immunisation Program (NIP).
![Photo of female doctor]()
The Australian Technical Advisory Group on Immunisation (ATAGI) has provided advice regarding alternatives during supply shortage of the adult formulations of hepatitis B vaccines.
![Get the facts baby image]()
The ‘Get the facts about immunisation’ campaign has launched to encourage Australian parents and carers to get their kids vaccinated.
![Influenza-image-man-tissue]()
The Australian Technical Advisory Group on Immunisation (ATAGI) has developed advice for immunisation providers regarding the administration of 2018 seasonal influenza vaccines.
![Immunisation coverage rates are improving]()
Coverage rates amongst Australian children continue to improve with 5 year old children having the highest coverage rates in history. 94% of Australian 5 year olds and over 96% of Aboriginal and Torres Strait Islander 5 year olds are now fully vaccinated.
![Default image]( "Default image")
Australia's medicine and medical devices regulator, the Therapeutic Goods Administration (TGA), has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).
![Three young kids image - public consutation re meningococcal and haemophilus tupe B vax recommendations]()
The Australian Technical Advisory Group on Immunisation is consulting with stakeholders on proposed changes to meningococcal and Haemophilus influenzae type B vaccination recommendations for inclusion in the Australian Immunisation Handbook.
![Radiologist and a patient]()
26,000 Australians per year will benefit from Medicare funding of new prostate MRI scans from July 1 2018.
![Default image]( "Default image")
An Expert Health Panel has been established to advise the Australian Government on the potential health impacts associated with per- and poly-fluoroalkyl substances (PFAS) exposure and to identify priority areas for further research.
![Default image]( "Default image")
All Australian Governments have agreed to initiate the third review of the National Scheme for the Regulation of Gene Technology (the Review). The Review will be led by a working group comprised of senior officials from Commonwealth and state and territory governments.
![Default image]( "Default image")
Following a decision by the European Commission to implement a number of medical device reforms, including to up-classify all surgical mesh medical devices to Class III and to provide patient implant cards and consumer product information for all implantable medical devices.
![Default image]( "Default image")
Pharmaceutical company Novo Nordisk A/S, in consultation with the TGA, has initiated a consumer level recall of some batches of their NovoPen Echo insulin cartridge holder after detecting there is a possibility they may crack or break if exposed to chemicals in certain cleaning agents.
![Default image]( "Default image")
The public and stakeholders now have an additional two weeks to provide input on the national Health Star Rating (HSR) system, as public consultation is extended until 17 August.
![Default image]( "Default image")
Media statement from Australia's Chief Medical Officer, Professor Brendan Murphy regarding media claims about flu vaccines.
![Default image]( "Default image")
Australia’s medicine and medical devices regulator, the TGA, has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).
![Default image]( "Default image")
The best medical advice and research shows that codeine is no better for pain than other over the counter medicines, Australia’s Chief Medical Officer, Professor Brendan Murphy, said today.
![Default image]( "Default image")
Australia’s Chief Medical Officer, Professor Brendan Murphy, has announced that a Voluntary Blood Testing Program for people impacted by PFAS contamination from RAAF Base Tindal in Katherine will begin on Saturday 17 March.
![Default image]( "Default image")
The Department of Health welcomes the Information Commissioner’s final report following his investigation into the department’s release of a sample of data from the Medicare Benefits Scheme (MBS) and Pharmaceutical Benefits Scheme (PBS).
![Default image]( "Default image")
Two cases of multi-drug resistant gonorrhoea have been recently detected in Australia. One case was diagnosed in Western Australia and a second case diagnosed in Queensland.
![Family standing in a field]()
A national immunisation coverage target provides a goal against which Australia can measure its immunisation coverage. The Global Vaccine Action Plan 2011-2020 encourages countries to demonstrate a commitment to immunisation.
Health portfolio news and events
For news and events from our portfolio agencies, go to Our portfolio for links to their websites.